(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Centogene N.V., Creative Realities, and Evofem Biosciences.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Centogene N.V. (CNTG)	1.63	120.27%	2023-04-26 01:11:07
2	Creative Realities (CREXW)	0.02	86.32%	2023-04-26 03:08:07
3	Evofem Biosciences (EVFM)	0.02	19.33%	2023-04-26 15:08:08
4	Chipotle Mexican Grill (CMG)	2035.09	14.33%	2023-04-26 13:39:26
5	Check-Cap Ltd. (CHEKZ)	0.02	14.12%	2023-04-25 21:10:07
6	MongoDB (MDB)	237.94	11.76%	2023-04-26 14:47:38
7	EyePoint Pharmaceuticals (EYPT)	7.66	11.41%	2023-04-26 15:49:07
8	Datadog (DDOG)	69.43	10.74%	2023-04-26 14:46:57
9	Microsoft (MSFT)	295.36	7.24%	2023-04-26 14:52:45
10	Ebang International Holdings (EBON)	6.01	6.94%	2023-04-26 10:43:10

The three biggest losers today are Evelo Biosciences, FIRST REPUBLIC BANK, and Entera Bio Ltd..

Rank	Financial Asset	Price	Change	Updated (EST)
1	Evelo Biosciences (EVLO)	0.10	-32.89%	2023-04-26 15:10:09
2	FIRST REPUBLIC BANK (FRC)	5.72	-29.32%	2023-04-26 14:52:01
3	Entera Bio Ltd. (ENTXW)	0.02	-26.47%	2023-04-26 11:48:08
4	Enphase Energy (ENPH)	163.45	-25.91%	2023-04-26 14:54:44
5	Calyxt (CLXT)	2.98	-14.52%	2023-04-25 23:48:06
6	Activision Blizzard (ATVI)	76.53	-11.77%	2023-04-26 13:35:18
7	Corbus Pharmaceuticals Holdings (CRBP)	9.01	-11.41%	2023-04-26 02:23:07
8	Old Dominion Freight Line (ODFL)	305.98	-9.84%	2023-04-26 14:57:33
9	DIRTT Environmental Solutions Ltd. (DRTT)	0.38	-9.8%	2023-04-26 07:47:07
10	Generac Holdlings (GNRC)	92.48	-9.42%	2023-04-26 14:52:12

Winners today

1. Centogene N.V. (CNTG) – 120.27%

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. The company develops rare disease platform, a data repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including RT-PCR and antigen testing services. It has a strategic collaboration with Shire International GmbH and Pfizer Inc.; a collaboration agreement with Dr. Bauer Laboratoriums GmbH, Rostock by providing the medical laboratory services to perform its COVID-19 testing business activities; and a license agreement with Fraport AG to operate a test center for COVID-19 testing/diagnostics at Frankfurt Airport, Germany, as well as Twist Bioscience Corporation to develop advanced sequencing tools. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

NASDAQ ended the session with Centogene N.V. rising 120.27% to $1.63 on Wednesday, after five successive sessions in a row of gains. NASDAQ rose 0.47% to $11,854.35, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Centogene N.V. has a trailing twelve months EPS of $-1.89.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -107.93%.

More news about Centogene N.V..

2. Creative Realities (CREXW) – 86.32%

NASDAQ ended the session with Creative Realities jumping 86.32% to $0.02 on Wednesday, after five successive sessions in a row of losses. NASDAQ jumped 0.47% to $11,854.35, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

More news about Creative Realities.

3. Evofem Biosciences (EVFM) – 19.33%

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.

NASDAQ ended the session with Evofem Biosciences jumping 19.33% to $0.02 on Wednesday, after four sequential sessions in a row of losses. NASDAQ rose 0.47% to $11,854.35, after two sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Evofem Biosciences has a trailing twelve months EPS of $-5.05.

Volume

Today’s last reported volume for Evofem Biosciences is 1106390 which is 72.16% below its average volume of 3974700.

Sales Growth

Evofem Biosciences’s sales growth is 263.3% for the ongoing quarter and 217.6% for the next.

Moving Average

Evofem Biosciences’s value is way under its 50-day moving average of $0.03 and way under its 200-day moving average of $0.20.

More news about Evofem Biosciences.

4. Chipotle Mexican Grill (CMG) – 14.33%

Chipotle Mexican Grill, Inc., together with its subsidiaries, owns and operates Chipotle Mexican Grill restaurants. It offers burritos, burrito bowls, quesadillas, tacos, and salads. The company was founded in 1993 and is headquartered in Newport Beach, California.

NYSE ended the session with Chipotle Mexican Grill jumping 14.33% to $2,035.09 on Wednesday while NYSE slid 0.88% to $15,228.58.

Earnings Per Share

As for profitability, Chipotle Mexican Grill has a trailing twelve months EPS of $31.68.

PE Ratio

Chipotle Mexican Grill has a trailing twelve months price to earnings ratio of 64.24. Meaning, the purchaser of the share is investing $64.24 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.54%.

Volume

Today’s last reported volume for Chipotle Mexican Grill is 1236530 which is 338.74% above its average volume of 281831.

Volatility

Chipotle Mexican Grill’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.35%, a positive 0.44%, and a positive 1.15%.

Chipotle Mexican Grill’s highest amplitude of average volatility was 0.40% (last week), 0.96% (last month), and 1.15% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 56.5% and 23.8%, respectively.

More news about Chipotle Mexican Grill.

5. Check-Cap Ltd. (CHEKZ) – 14.12%

NASDAQ ended the session with Check-Cap Ltd. rising 14.12% to $0.02 on Wednesday, after five successive sessions in a row of losses. NASDAQ rose 0.47% to $11,854.35, after two consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Yearly Top and Bottom Value

Check-Cap Ltd.’s stock is valued at $0.02 at 17:32 EST, higher than its 52-week high of $0.02.

More news about Check-Cap Ltd..

6. MongoDB (MDB) – 11.76%

MongoDB, Inc. provides general purpose database platform worldwide. The company offers MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premise, or in a hybrid environment; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It also provides professional services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.

NASDAQ ended the session with MongoDB jumping 11.76% to $237.94 on Wednesday, after two successive sessions in a row of losses. NASDAQ jumped 0.47% to $11,854.35, after two successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, MongoDB has a trailing twelve months EPS of $-4.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.13%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MongoDB’s EBITDA is 11.03.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MongoDB’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

MongoDB’s stock is valued at $237.94 at 17:32 EST, way under its 52-week high of $420.96 and way above its 52-week low of $135.15.

More news about MongoDB.

7. EyePoint Pharmaceuticals (EYPT) – 11.41%

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery. It is also developing EYP-1901, a twice-yearly bioerodible formulation of tyrosine kinase inhibitor that is in Phase 1 clinical trials for the treatment of wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion; and YUTIQ50 for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. It also has a commercial alliance with ImprimisRx PA, Inc. for the joint promotion of DEXYCU for the treatment of post-operative inflammation following ocular surgery. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

NASDAQ ended the session with EyePoint Pharmaceuticals jumping 11.41% to $7.66 on Wednesday, after two consecutive sessions in a row of losses. NASDAQ jumped 0.47% to $11,854.35, after two sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, EyePoint Pharmaceuticals has a trailing twelve months EPS of $-2.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.84%.

Yearly Top and Bottom Value

EyePoint Pharmaceuticals’s stock is valued at $7.66 at 17:32 EST, way below its 52-week high of $12.33 and way above its 52-week low of $2.19.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 21.4% and a negative 34.6%, respectively.

Volume

Today’s last reported volume for EyePoint Pharmaceuticals is 3671490 which is 401.7% above its average volume of 731809.

More news about EyePoint Pharmaceuticals.

8. Datadog (DDOG) – 10.74%

Datadog, Inc. operates an observability and security platform for cloud applications in North America and internationally. The company's products include infrastructure and application performance monitoring, log management, digital experience monitoring, continuous profiler, database monitoring, network monitoring, incident management, observability pipelines, cloud cost management, universal service monitoring, cloud security management, application security management. cloud SIEM, sensitive data scanner, and CI Visibility. The company was incorporated in 2010 and is headquartered in New York, New York.

NASDAQ ended the session with Datadog rising 10.74% to $69.43 on Wednesday while NASDAQ rose 0.47% to $11,854.35.

: datadog stock soars as Microsoft commentary helps fuel hopes of reaccelerationShares of Datadog Inc. DDOG were rocketing 14% in midday trading Wednesday, which one analyst attributed to commentary from Microsoft Corp. MSFT about its Azure cloud-computing business.

Earnings Per Share

As for profitability, Datadog has a trailing twelve months EPS of $-0.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.09%.

More news about Datadog.

9. Microsoft (MSFT) – 7.24%

Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exchange, SharePoint, Microsoft Teams, Office 365 Security and Compliance, Microsoft Viva, and Skype for Business; Skype, Outlook.com, OneDrive, and LinkedIn; and Dynamics 365, a set of cloud-based and on-premises business solutions for organizations and enterprise divisions. The Intelligent Cloud segment licenses SQL, Windows Servers, Visual Studio, System Center, and related Client Access Licenses; GitHub that provides a collaboration platform and code hosting service for developers; Nuance provides healthcare and enterprise AI solutions; and Azure, a cloud platform. It also offers enterprise support, Microsoft consulting, and nuance professional services to assist customers in developing, deploying, and managing Microsoft server and desktop solutions; and training and certification on Microsoft products. The More Personal Computing segment provides Windows original equipment manufacturer (OEM) licensing and other non-volume licensing of the Windows operating system; Windows Commercial, such as volume licensing of the Windows operating system, Windows cloud services, and other Windows commercial offerings; patent licensing; and Windows Internet of Things. It also offers Surface, PC accessories, PCs, tablets, gaming and entertainment consoles, and other devices; Gaming, including Xbox hardware, and Xbox content and services; video games and third-party video game royalties; and Search, including Bing and Microsoft advertising. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online stores, and retail stores. Microsoft Corporation was founded in 1975 and is headquartered in Redmond, Washington.

NASDAQ ended the session with Microsoft rising 7.24% to $295.36 on Wednesday, after four consecutive sessions in a row of losses. NASDAQ jumped 0.47% to $11,854.35, after two consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Why U.K. is blocking Microsoft takeover of activision — and what happens nextA U.K. regulator made the surprising decision Wednesday to block Microsoft Corp.’s deal for Activision Blizzard Inc. in a further sign of resistance to the power of Big Tech.

Activision shares plunge as U.K. regulator says it will block Microsoft purchaseThe U.K. regulator says it would block Microsoft Corp.’s mega-deal for videogame publisher Activision Blizzard Inc., citing the potential for negative impacts on competition in the cloud-gaming market., The U.K.’s Competition and Markets Authority said Wednesday that it would prohibit the merger as it could make Microsoft stronger in the market for global cloud-gaming services.

: Microsoft stock rallies toward record price gain, adds more than 130 points to the dow’s priceShares of Microsoft Corp. MSFT shot up 7.4% toward a one-year high in premarket trading Wednesday, in the wake of better-than-expected earnings and guidance, enough to pace the Dow Jones Industrial Average’s DJIA early gainers.

Earnings Per Share

As for profitability, Microsoft has a trailing twelve months EPS of $9.12.

PE Ratio

Microsoft has a trailing twelve months price to earnings ratio of 32.39. Meaning, the purchaser of the share is investing $32.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.31%.

Previous days news about Microsoft

: NVIDIA stock gains as Microsoft details plans to spend on AI infrastructure. According to MarketWatch on Tuesday, 25 April, "Nvidia Corp. NVDA shares jumped more than 2.5% in after-hours trading Tuesday after Microsoft Corp. MSFT executives detailed increased spending on equipment needed to offer artificial-intelligence-powered features to corporate customers. "

More news about Microsoft.

10. Ebang International Holdings (EBON) – 6.94%

Ebang International Holdings Inc., through its subsidiaries, engages in the research, design, and development of application-specific integrated circuit chips and manufacture of Bitcoin mining machines in China, the United States, Hong Kong, and internationally. It also provides mining machine hosting services that enable customers to operate mining machines remotely, as well as offers routine maintenance services. In addition, the company engages in the research, development, manufacture, and sale of fiber optical telecommunication products, including PDH fiber optical multiplexers, E+E fiber optical multiplexers, 1+1 dual fiber interface back-up fiber optical multiplexers, voice fiber optical multiplexers, date video fiber optical multiplexers, fiber modems, protocol converters, optical fiber transceivers, timeslot multiplexers, PAS repeaters, and others, as well as transmission network and converged communication products. Further, it offers enterprise convergent terminal products, including gigabit passive optical network, enterprise cloud gateway devices, industrial Internet of Things access devices, and business enterprise smart wireless access devices. The company offers Bitcoin mining machines under the Ebit brand. It serves blockchain and telecommunications industries. The company sells its blockchain products directly, as well as through its website; and telecommunication products under the EBANG brand name primarily through supplier contracts. Ebang International Holdings Inc. was incorporated in 2018 and is headquartered in Hangzhou, China.

NASDAQ ended the session with Ebang International Holdings jumping 6.94% to $6.01 on Wednesday, after three successive sessions in a row of losses. NASDAQ rose 0.47% to $11,854.35, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Ebang International Holdings has a trailing twelve months EPS of $-0.29.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.09%.

Yearly Top and Bottom Value

Ebang International Holdings’s stock is valued at $6.01 at 17:32 EST, way below its 52-week high of $31.20 and way above its 52-week low of $2.52.

Volume

Today’s last reported volume for Ebang International Holdings is 24596 which is 35.05% below its average volume of 37872.

More news about Ebang International Holdings.

Losers Today

1. Evelo Biosciences (EVLO) – -32.89%

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in clinical development trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also engages in developing EDP1867, an inactivated investigational oral biologic for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Evelo Biosciences sliding 32.89% to $0.10 on Wednesday while NASDAQ rose 0.47% to $11,854.35.

Earnings Per Share

As for profitability, Evelo Biosciences has a trailing twelve months EPS of $-1.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6232.76%.

Yearly Top and Bottom Value

Evelo Biosciences’s stock is valued at $0.10 at 17:32 EST, way under its 52-week high of $3.29 and higher than its 52-week low of $0.10.

Moving Average

Evelo Biosciences’s worth is way below its 50-day moving average of $0.38 and way below its 200-day moving average of $1.55.

More news about Evelo Biosciences.

2. FIRST REPUBLIC BANK (FRC) – -29.32%

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, and private wealth management services to clients in metropolitan areas in the United States. It operates in two segments, Commercial Banking and Wealth Management. The company accepts deposit products, such as noninterest-bearing checking, interest-bearing checking, money market checking accounts, money market savings accounts, and passbook accounts, as well as certificates of deposit. It also offers a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate and construction loans, personal and business loans, single family construction loans, and other loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, online investment management, trust and custody, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. Further, the company offers online and mobile banking services; refinancing services; and ATM and debit cards. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

NYSE ended the session with FIRST REPUBLIC BANK falling 29.32% to $5.72 on Wednesday, after two successive sessions in a row of losses. NYSE fell 0.88% to $15,228.58, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, FIRST REPUBLIC BANK has a trailing twelve months EPS of $9.26.

PE Ratio

FIRST REPUBLIC BANK has a trailing twelve months price to earnings ratio of 0.62. Meaning, the purchaser of the share is investing $0.62 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.

Yearly Top and Bottom Value

FIRST REPUBLIC BANK’s stock is valued at $5.72 at 17:32 EST, way below its 52-week low of $11.52.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 57.5% and a negative 102.3%, respectively.

Moving Average

FIRST REPUBLIC BANK’s worth is way below its 50-day moving average of $74.11 and way under its 200-day moving average of $121.44.

More news about FIRST REPUBLIC BANK.

3. Entera Bio Ltd. (ENTXW) – -26.47%

NASDAQ ended the session with Entera Bio Ltd. sliding 26.47% to $0.02 on Wednesday, after five sequential sessions in a row of losses. NASDAQ rose 0.47% to $11,854.35, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Yearly Top and Bottom Value

Entera Bio Ltd.’s stock is valued at $0.02 at 17:32 EST, way under its 52-week low of $0.02.

More news about Entera Bio Ltd..

4. Enphase Energy (ENPH) – -25.91%

Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level, and combines with its proprietary networking and software technologies to provide energy monitoring and control services. It also provides microinverter units and related accessories, an IQ gateway; IQ batteries; the cloud-based Enlighten monitoring service; storage solutions; and electric vehicle charging solutions; and design, proposal, permitting, and lead generation services. The company sells its solutions to solar distributors; and directly to large installers, original equipment manufacturers, strategic partners, and homeowners, as well as through its legacy product upgrade program or online store. Enphase Energy, Inc. was incorporated in 2006 and is headquartered in Fremont, California.

NASDAQ ended the session with Enphase Energy falling 25.91% to $163.45 on Wednesday while NASDAQ rose 0.47% to $11,854.35.

Earnings Per Share

As for profitability, Enphase Energy has a trailing twelve months EPS of $2.79.

PE Ratio

Enphase Energy has a trailing twelve months price to earnings ratio of 58.58. Meaning, the purchaser of the share is investing $58.58 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.29%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 51.9% and 18.7%, respectively.

Volume

Today’s last reported volume for Enphase Energy is 24148700 which is 516.74% above its average volume of 3915510.

Previous days news about Enphase Energy

Enphase energy (enph) beats Q1 earnings and revenue estimates. According to Zacks on Tuesday, 25 April, "While Enphase Energy has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Enphase Energy.

5. Calyxt (CLXT) – -14.52%

Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to support various research projects; and a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and various geographies outside the United States. It also has a strategic alliance with J.R. Simplot Company to drive new breeding techniques for strawberries, including gene editing. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

NASDAQ ended the session with Calyxt sliding 14.52% to $2.98 on Wednesday while NASDAQ rose 0.47% to $11,854.35.

Earnings Per Share

As for profitability, Calyxt has a trailing twelve months EPS of $-4.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -158.12%.

Moving Average

Calyxt’s worth is way below its 50-day moving average of $3.54 and way higher than its 200-day moving average of $2.47.

Yearly Top and Bottom Value

Calyxt’s stock is valued at $2.98 at 17:32 EST, way below its 52-week high of $5.27 and way higher than its 52-week low of $1.25.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 53.8% and a drop 20% for the next.

More news about Calyxt.

6. Activision Blizzard (ATVI) – -11.77%

Activision Blizzard, Inc., together with its subsidiaries, develops and publishes interactive entertainment content and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision, Blizzard, and King. It develops and distributes content and services on video game consoles, personal computers, and mobile devices, including subscription, full-game, and in-game sales, as well as by licensing software to third-party or related-party companies that distribute Activision and Blizzard products. The company also maintains a proprietary online gaming service, Battle.net that facilitates digital distribution of content, online social connectivity, and the creation of user-generated content. In addition, it operates esports leagues and offer digital advertising content; and provides warehousing, logistics, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company's key product franchises include Call of Duty, World of Warcraft, Diablo, Hearthstone, Overwatch, Overwatch League, and Candy Crush. It serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores through third-party distribution and licensing arrangements. The company is headquartered in Santa Monica, California.

NASDAQ ended the session with Activision Blizzard dropping 11.77% to $76.53 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ rose 0.47% to $11,854.35, after two sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Activision Blizzard has a trailing twelve months EPS of $1.92.

PE Ratio

Activision Blizzard has a trailing twelve months price to earnings ratio of 39.86. Meaning, the purchaser of the share is investing $39.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.

More news about Activision Blizzard.

7. Corbus Pharmaceuticals Holdings (CRBP) – -11.41%

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. Its lead product candidate is lenabasum, a cannabinoid receptor type 2 (CB2) that is in Phase III clinical trial for the treatment of dermatomyositis; and in Phase II clinical trial to treat systemic lupus erythematosus. The company is also developing cannabinoid receptor type 1 inverse agonist program for treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; and CB2 agonist program for the treatment of cancer. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

NASDAQ ended the session with Corbus Pharmaceuticals Holdings dropping 11.41% to $9.01 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.47% to $11,854.35, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Corbus Pharmaceuticals Holdings has a trailing twelve months EPS of $-11.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -82.95%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 70.4% and positive 28.8% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Corbus Pharmaceuticals Holdings’s EBITDA is 2.49.

Volume

Today’s last reported volume for Corbus Pharmaceuticals Holdings is 115205 which is 75.69% below its average volume of 474017.

Yearly Top and Bottom Value

Corbus Pharmaceuticals Holdings’s stock is valued at $9.01 at 17:32 EST, way below its 52-week high of $13.17 and way higher than its 52-week low of $2.11.

More news about Corbus Pharmaceuticals Holdings.

8. Old Dominion Freight Line (ODFL) – -9.84%

Old Dominion Freight Line, Inc. operates as a less-than-truckload (LTL) motor carrier in the United States and North America. It provides regional, inter-regional, and national LTL services, including expedited transportation. The company also offers various value-added services, such as container drayage, truckload brokerage, and supply chain consulting. As of December 31, 2022, it owned and operated 11,274 tractors, 31,252 linehaul trailers, and 14,315 pickup and delivery trailers; 44 fleet maintenance centers; and 255 service centers. Old Dominion Freight Line, Inc. was founded in 1934 and is headquartered in Thomasville, North Carolina.

NASDAQ ended the session with Old Dominion Freight Line dropping 9.84% to $305.98 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.47% to $11,854.35, after two sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Old Dominion Freight Line has a trailing twelve months EPS of $12.18.

PE Ratio

Old Dominion Freight Line has a trailing twelve months price to earnings ratio of 25.12. Meaning, the purchaser of the share is investing $25.12 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.56%.

Moving Average

Old Dominion Freight Line’s value is way below its 50-day moving average of $340.74 and above its 200-day moving average of $301.53.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Old Dominion Freight Line’s EBITDA is 71.89.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 6.26B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Old Dominion Freight Line’s stock is considered to be overbought (>=80).

More news about Old Dominion Freight Line.

9. DIRTT Environmental Solutions Ltd. (DRTT) – -9.8%

DIRTT Environmental Solutions Ltd. designs, manufactures, and installs prefabricated interior solutions for use primarily in commercial spaces across various industries and businesses in the United States, Canada, internationally. Its ICE software interior construction technology provides integration and management, from design through engineering, manufacturing, and installation. The company's interior construction solutions include prefabricated, customized interior modular walls, ceilings, and floors; decorative and functional millwork; power infrastructure; network infrastructure; and pre-installed medical gas piping systems. It offers interior construction solutions through a network of independent distribution partners. It serves commercial, healthcare, education, hospitality, and other industries, as well as medical gas piping systems for healthcare. DIRTT Environmental Solutions Ltd. was incorporated in 2003 and is headquartered in Calgary, Canada.

NASDAQ ended the session with DIRTT Environmental Solutions Ltd. falling 9.8% to $0.38 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.47% to $11,854.35, after two sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, DIRTT Environmental Solutions Ltd. has a trailing twelve months EPS of $-0.62.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -128.18%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

DIRTT Environmental Solutions Ltd.’s EBITDA is -30.74.

More news about DIRTT Environmental Solutions Ltd..

10. Generac Holdlings (GNRC) – -9.42%

Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, energy management devices and solutions, and other power products for the residential, light commercial, and industrial markets worldwide. The company offers residential automatic standby generators, automatic transfer switch, air-cooled engine residential standby generators, and liquid-cooled engine generators; residential storage solution consists of a system of batteries, an inverter, photovoltaic optimizers, power electronic controls, and other components; Mobile Link, a remote monitoring system for home standby generators; smart home solutions, such as smart thermostats and a suite of home monitoring products; smart water heater controllers; residential clean energy solutions; and portable and inverter generators; outdoor power equipment, including trimmers, field and brush mowers, log splitters, stump grinders, chipper shredders, lawn and leaf vacuums, and pressure washers and water pumps; and battery-powered turf care products. It also provides commercial and industrial products comprising cleaner-burning natural gas fueled generators; light-commercial standby generators and related transfer switches; stationary generators and related transfer switches; single-engine industrial generators; industrial standby generators; industrial transfer switches; light towers, mobile generators, and mobile energy storage systems; and aftermarket service parts and product accessories. The company distributes its products through independent residential dealers, industrial distributors and dealers, national and regional retailers, e-commerce partners, electrical, HVAC and solar wholesalers, catalogs, equipment rental companies and distributors, and solar installers; and directly to end users. The company was founded in 1959 and is headquartered in Waukesha, Wisconsin.

NYSE ended the session with Generac Holdlings falling 9.42% to $92.48 on Wednesday, after two sequential sessions in a row of losses. NYSE fell 0.88% to $15,228.58, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Generac Holdlings has a trailing twelve months EPS of $5.38.

PE Ratio

Generac Holdlings has a trailing twelve months price to earnings ratio of 17.19. Meaning, the purchaser of the share is investing $17.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.62%.

Moving Average

Generac Holdlings’s worth is way below its 50-day moving average of $115.28 and way under its 200-day moving average of $151.58.

Volatility

Generac Holdlings’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.01%, a negative 0.55%, and a positive 2.52%.

Generac Holdlings’s highest amplitude of average volatility was 1.08% (last week), 1.80% (last month), and 2.52% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Generac Holdlings’s EBITDA is 53.44.

More news about Generac Holdlings.

Stay up to date with our winners and losers daily report